Buscar
Congreso SOLACI
HomeCoronary diseaseChronic Ischemic cardiopathy

Chronic Ischemic cardiopathy

Ver Categoría

Chronic Ischemic cardiopathy

Coronary Physiology Is Useful in Chronic Kidney Disease

Coronary physiology, FFR and iFR, has been shown safe to defer lesions and effective to save stents...
solaci -
Ver más
Chronic Ischemic cardiopathy

Changes in Coronary Collateral Function Post CTO Intervention

In the last few years, we have seen significant growth of chronic total occlusion (CTO) percutaneous intervention,...
solaci -
Ver más
Antiplatelet

An Abbreviated Dual Antiplatelet Regimen Is Also Safe in Patients at High Risk for Bleeding Undergoing Complex Angioplasty

The MASTER DAPT study analyzed the results of an abbreviated (mean 34 days) vs. conventional dual antiplatelet...
solaci -
Ver más
Chronic Ischemic cardiopathy

Prognostic Value of Structural and Functional Microvascular Dysfunction in Patients with Nonobstructive Coronary Artery Disease

Coronary microvascular dysfunction (CMD) is a paramount factor involved in the development of anginal syndromes. Among patients...
solaci -
Ver más
Chronic Ischemic cardiopathy

Hand Function after Distal Radial Access: Is it Safe?

The benefit of the transradial approach in percutaneous interventions is well known. Its main limitation is radial...
solaci -
Ver más
Chronic Ischemic cardiopathy

FFR and IFR: Are We Talking About the Same Thing?

To evaluate borderline coronary lesions (a 40% to 70% obstruction), determining associated ischemia is paramount. For this...
solaci -
Ver más
Chronic Ischemic cardiopathy

Improved Ventricular Function Post Revascularization: Fewer Events across Subgroups?

According to the STITCH and STITCHES trials, in patients with coronary artery disease and deteriorated left ventricular...
solaci -
Ver más
Chronic Ischemic cardiopathy

Can the Use of Intra Arterial Vasodilators Prevent Radial Artery Occlusion?

The incidence of post procedure radial occlusion (RAO) ranges from 1% to 12 % according to some...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 0
Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad